All You Need to Know on the Ecuador Sessions 2020

After 3 years, SOLACI returns to Ecuador -this time to the beautiful city of Manta- to continue promoting the development of interventional cardiology in Latin America. Do not hesitate to participate in this important event that will undoubtedly be enriching for medical practice and, also, to improve the quality of life of patients in our region.

Jornadas Ecuador 2020

Below you will find all the relevant information you need to know about the Ecuador Regional Sessions 2020.

When?

March 6th & 7th, 2020.

Where?

They will take place in Manta, Ecuador. (Oro Verde Hotel).

How can I register?

By entering HERE.

Which are the registrations fees?

  • Specialists | USD 160.
  • Generales Physicians | USD 130.
  • Students | USD 100.
  • Technicians & Nurses | USD 80.

Scientific Program

Access the scientific program

Which are the relevant topics?

  • Acute Coronary Syndrome
  • Coronary interventionism.
  • Aortic Valve Interventions.
  • Mitral valve.
  • Antithrombotic Therapy
  • Atrial Fibrillation Intervention.
  • Pediatric intervention.
  • Live cases.
  • Clinical Case Contest for Young Interventionists
  • Imagen Contest.

Who are organizing these sessions?

The Latin American Society of Interventional Cardiology alongside with the Ecuadorian Society of Cardiovascular Interventions (SEICAV).

Contact

¿En qué consiste el Concurso de Imágenes?

It is an interactive activity consisting in the presentation of a case series based on imaging. One or more multiple-choice questions will be asked regarding these cases. Participants will send their answers through their smartphones, which will connect to the evaluation information system. The Contest will also include a few questions on general knowledge for entertainment purposes. The participant with more correct answers will be the winner. Its first price will be the fee for full registration, lodging and transportation costs to Chile Sessions 2016 (November 30th and December 1st).

What are the winners of the Imaging and Clinical Case Contests awarded?

All costs to some of the next SOLACI Sessions will be waived.

SOLACI Board

Jornadas SOLACI Director
Dr. Mario Araya (Chile).

Jornadas SOLACI Vice Director
Dr. Gustavo Vignolo (Uruguay).

SOLACI Sessions Scientific Committee Director
Dr. Marcio Montenegro (Brasil).

SEICAV Board

SEICAV President
Dr. Gustavo Hidalgo.

SEICAV Vice President
Dr. José Vivas Guijarro.

SEICAV Secretary
Dr. Alfonso Zambrano.

 SEICAV Pro-secretary
Dr. Wishton Moreira.

SEICAV Vocal
Dr. Ricardo Ortíz.

SEICAV Vocal
Dr. Erwin Téllez.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Fellow’s Corner – Case 1: Chronic Total Occlusion Treated via Retrograde Approach. A True Challenge

Share your experience. Learn from experts. Grow as an interventionalist. We present the first case of this new edition of The Fellow’s Corner, an academic...

Call For Science SOLACI & SBHCI 2026 – Submit Your Work!

We invite you to submit scientific papers and challenging clinical cases for the SOLACI & SBHCI 2026 Congress, taking place from July 29 to...

Watch again “Ultrasound Pulses + Calcium = Coronary Lithotripsy” | SOLACI Technicians Webinar

The webinar “Ultrasound Pulses + Calcium = Coronary Lithotripsy”, held on March 24, 2026 via the Zoom platform, is now available for viewing on...

SOLACI invites you to the 5th International Conference on Clinical and Interventional Cardiology in the Dominican Republic

The Latin American Society of Interventional Cardiology (SOLACI) invites the community to the 5th International Conference on Clinical and Interventional Cardiology (Coronary and Structural),...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...